The Growth Buyout team at Frazier Healthcare Partners invests in healthcare services and products. The hedge fund focuses on acquiring controlling stakes in healthcare companies with EBITDA of $10 million to $75 million, in which it can invest $50 million to $300 million. The biotech industry is gaining traction among investors due to its long-term growth prospects. The stock of Moderna, Inc. soared to new highs after Indian drugmaker Cipla Ltd granted permission to distribute partner Moderna’s vaccine in the nation.
Here is Insider Monkey’s list of the 10 best biotech stocks to buy according to Alan Frazier. One of the top biotech stocks to buy is Gritstone Bio, Inc. The business is working on producing tumor-specific cancer immunoglobulins to combat cancer and infectious illnesses. Gilead Sciences and Gritstone Oncology cooperated to study and develop an HIV vaccine-based vaccination. The biotherapeutics business, Molecular Templates, Inc., discovers and develops medications to treat cancer and other disorders. According to Alan Frazier, the company is ranked ninth among the top ten biotech stocks to purchase. According to Alan Frazier, AnaptysBio, Inc. is the sixth best biotech stock to purchase. The firm is a biotechnology firm focused on the development of drugs to treat inflammation and immuno-oncology disorders. Sutro Biopharma, Inc. stock has increased in value by 139.25 percent in the last year. The company’s goal is to develop cancer protein therapies. Alan Frazier ranks it sixth among the top ten biotech stocks to purchase. Syndax Pharmaceuticals, Inc. has returned 19.52 percent to investors in the last year. The company was founded in 2005 and is currently ranked sixth among the top ten biotech stocks to purchase. For more details, click 10 Best Biotech Stocks to Buy According to Alan Frazier.
